AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

283 hedge funds and large institutions have $3.9B invested in Amedisys in 2019 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 106 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

3% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 32

44% less call options, than puts

Call options by funds: $23.8M | Put options by funds: $42.2M

Holders
283
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$23.8M
Puts
$42.2M
Net Calls
Net Calls Change

Top Buyers

1 +$84.6M
2 +$71.2M
3 +$27.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.6M
5
BlackRock
BlackRock
New York
+$16.9M
Name Holding Trade Value Shares
Change
Change in
Stake
201
$400K
202
$394K
203
$392K
204
$389K
205
$382K
206
$382K
207
$361K
208
$359K
209
$353K
210
$349K
211
$330K
212
$326K
213
$315K
214
$310K
215
$304K
216
$288K
217
$284K
218
$278K
219
$272K
220
$262K
221
$260K
222
$259K
223
$254K
224
$252K
225
$251K